From: LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway
medicine
IC50 (μM) ± SD
MCF-7
MCF-7/OE-CBR3-AS1
MCF-7/ADR
MCF-7/ADR-si-CBR3-AS1-1
MCF-7/ADR-si-CBR3-AS1-2
ADR
0.11±0.02
0.28±0.05
30.16±3.13
8.54±2.65
10.37±1.94